Why the study?
Does the Total Thrombus-formation Analysis System predict periprocedural bleeding events in patients with coronary artery disease undergoing percutaneous coronary intervention?
Does the Total Thrombus-formation Analysis System predict periprocedural bleeding events in patients with coronary artery disease undergoing percutaneous coronary intervention?
The Total Thrombus-formation Analysis System is suggested as a potentially useful predictor of periprocedural bleeding events in CAD patients undergoing elective PCI.
Answers are grounded in this paper and cite their sources.
T-TAS levels do not predict bleeding with radial PCI; leaves open utility in broader or femoral-access cohorts.
BACKGROUND: Periprocedural bleeding events are common after percutaneous coronary intervention. We evaluated the association of periprocedural bleeding events with thrombogenicity, which was measured quantitatively by the Total Thrombus-formation Analysis System equipped with microchips and thrombogenic surfaces (collagen, platelet chip [PL]; collagen plus tissue factor, atheroma chip [AR]). METHODS AND RESULTS: levels in 127 patients of the radial approach group were not significantly different in patients with or without periprocedural bleeding events. CONCLUSIONS: measured by the Total Thrombus-formation Analysis System is a potentially useful predictor of periprocedural bleeding events in coronary artery disease patients undergoing elective percutaneous coronary intervention.
No takes yet. Share an insight, caveat, or question.
Oimatsu et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: